Expression vector with DNA of bovine papilloma virus 1 for keratinocyte gene therapy
- 1 June 2000
- journal article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 23 (2) , 111-116
- https://doi.org/10.1016/s0923-1811(99)00095-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin.Journal of Clinical Investigation, 1998
- In Vivo Transfer of Foreign Gene to Keratinocytes Using the Hemagglutinating Virus of Japan-Liposome MethodJournal of Investigative Dermatology, 1997
- Cytokine gene expression in epidermis with biological effects following injection of naked DNANature Genetics, 1995
- Construction of a Novel Bovine Papillomavirus Vector Without Detectable Transforming Activity Suitable for Gene TransferHuman Gene Therapy, 1995
- Epidermis: An Attractive Target Tissue for Gene TherapyJournal of Investigative Dermatology, 1994
- Ex Vivo and In Vivo Gene Transfer to The Skin Using Replication-Deficient Recombinant Adenovirus VectorsJournal of Investigative Dermatology, 1994
- Keratinocyte Gene TherapyArchives of Dermatology, 1993
- In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment.Proceedings of the National Academy of Sciences, 1993
- Expression vector system based on the chicken β-actin promoter directs efficient production of interleukin-5Gene, 1989
- Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectorsEuropean Journal of Immunology, 1988